SHP Share PerformanceMore
|52 week high||5,377.0 20/09/16|
|52 week low||2,707.0 13/07/16|
|52 week change||216.0 (5.24%)|
|4 week volume||34,761,833 28/12/16|
Latest News« previous» nextMore
16/01/2017 - 12:00 RNS
Director/PDMR Shareholding January 16, 2017 ? Shire plc (LSE: SHP, NASDAQ: SHPG) (the ?Company?) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial responsibilities (?PDMR?) / person closely associated with them (?PCA?) a) Name Jeff Poulton 2. Reason for the notification a) Position / st...
06/01/2017 - 11:00 RNS
Director Declaration January 6, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the ?Company?) announces that Ian Clark, Non-Executive Director of the Company, was appointed to the Board of Directors of Kite Pharma, Inc. on January 5, 2017. This notification is to satisfy the Company?s obligations under LR 9.6.14R of the UK Listing Rules. Oliver Strawbridge Senio...
04/01/2017 - 15:00 RNS
Director Declaration January 4, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the ?Company?) announces that Ian Clark, Non-Executive Director of the Company, was appointed to the Boards of Directors of Agios Pharmaceuticals, Inc. and Corvus Pharmaceuticals, Inc. on January 3, 2017. This notification is to satisfy the Company?s obligations under LR 9.6.14R of the...
04/01/2017 - 12:10 StockMarketWire
JP Morgan Cazenove today reaffirms its overweight investment rating on Shire PLC (LON:SHP) and cut its price target to...
03/01/2017 - 12:00 RNS
Total Voting Rights January 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the ?Company?), in accordance with 5.6.1R of the Financial Conduct Authority's (the ?FCA?) Disclosure Rules and Transparency Rules, notifies the market of the following: As at December 31, 2016, the Company?s issued ordinary share capital comprised 904,202,151 ordinary shares of 5 pence e...
03/01/2017 - 07:17 StockMarketWire
Shire announces the appointment of Ian Clark as a non-executive director with effect.
03/01/2017 - 07:00 RNS
Directorate change Appointment of Ian Clark as Non-Executive Director January 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (?Shire?? / the ?Company?) announces the appointment of Ian Clark as a Non-Executive Director of the Company with effect from the date of this announcement. Mr. Clark served as Chief Executive Officer and Director of Genentech In...
22/12/2016 - 11:10 Interactive Investor
Despite the many storms brewing, there will be opportunities to make money in 2017. Lee Wild reveals the 23 shares tipped...
Latest discussion posts More
“The funds I invest in are buying into the fear. Shire hold exactly the type of drugs aimed at pensioners that Trump is aims to target hence why it is trading very cheaply. ...”▼
“"So not surprising that Shire is falling" Hopefully it's had it's beating and could rise up to and over the rest of Christmas into the new year. Just added this morning at ...”▼
“Trump has warned that he will deal with Pharma overpricing of drugs. So not surprising that Shire is falling”▼
Codes & Symbols
|Symbols||SHP, LSE:SHP, SHP.L, SHP:LN, LON:SHP, XLON:SHP|